Judson Ratliff

Title: Innovations of Judson Ratliff in Clinical Formulations

Introduction

Judson Ratliff is an accomplished inventor based in Harvard, MA (US), known for his significant contributions to the field of clinical formulations. With a total of three patents to his name, Ratliff has made strides in enhancing the viability and efficiency of cell and tissue preparations.

Latest Patents

Ratliff's latest patents focus on clinical media that support the viability, re-plating efficiency, and repopulation capacity of cells and tissues during storage for extended periods, specifically up to 48 hours or longer. These clinical media are also beneficial for clinical irrigation. His patents include methods for generating cell or tissue preparations that comprise a cell population or tissue along with the clinical medium. Furthermore, he has disclosed methods for using these clinical media and preparations to administer effective amounts of cells or tissue to subjects in need.

Career Highlights

Judson Ratliff is currently associated with the Astellas Institute for Regenerative Medicine, where he continues to innovate in the field of regenerative medicine. His work is pivotal in advancing clinical applications that can significantly impact patient care.

Collaborations

Ratliff collaborates with notable colleagues, including Roger Gay and Romma E Southwick, contributing to a dynamic research environment that fosters innovation and development in clinical formulations.

Conclusion

Judson Ratliff's work in clinical formulations exemplifies the intersection of innovation and practical application in medicine. His patents and ongoing research hold promise for improving the efficacy of cell and tissue therapies.